Endocrine System Articles A-Z
Drug Interactions With Rosiglitazone and Metformin
Estrogens, diuretics, and Norvasc may cause drug interactions with rosiglitazone and metformin. This eMedTV resource explains what may happen during these interactions and lists other medicines that can lead to an interaction with this drug.
Drug Interactions With Sitagliptin
Drug interactions with sitagliptin are primarily limited to digoxin at this time. As this eMedTV Web page explains, when these two medications are combined, it can increase the level of digoxin in your blood.
Empty sella syndrome is a condition in which the pituitary gland becomes flattened or shrinks. As this eMedTV article explains, this change in the pituitary gland makes the area of the brain that protects it (the sella turcica) appear empty.
Exenatide is a prescription drug that is licensed to lower blood sugar in people with type 2 diabetes. This eMedTV page explains how exenatide works to increase insulin production, lists potential side effects, and covers general dosing guidelines.
As this eMedTV page explains, the recommended starting exenatide dosage is usually 5 mcg injected twice daily. If necessary, the dose may be increased after one month to 10 mcg twice daily. This page also outlines some tips on taking the injections.
This eMedTV resource discusses how exenatide treats type 2 diabetes by increasing the production of insulin and decreasing the production of sugar. This page also explains that there are no universally accepted off-label exenatide uses.
This eMedTV segment explains that exenatide can be prescribed as a treatment for type 2 diabetes. Exenatide works by lowering blood sugar levels. This page also outlines some alternatives to exenatide. Exenitide is a common misspelling of exenatide.
This eMedTV article explains that a patent currently prevents any generic acarbose from being manufactured and sold until September 2009, when the patent expires. This page also warns people not to buy any product currently sold as "generic acarbose."
Some generic drugs have the same components as Armour Thyroid (thyroid USP), but, as this eMedTV article explains, it's difficult to know if these products are equivalent to Armour Thyroid. They may not truly be considered a generic Armour Thyroid.
There is currently a generic glimepiride available for sale in six different strengths. This portion of the eMedTV library highlights the different dosages available and lists the companies that currently manufacture generic glimepiride.
Generic Glucophage (metformin) is available in five different strengths and also in a long-acting version. This eMedTV article outlines the various strengths of generic Glucophage and also discusses who makes the drug.
A generic Glucotrol and Glucotrol XL are currently available for sale. This page of the eMedTV archives explains how the FDA rates generic versions of brand-name drugs and what this means with regards to Glucotrol (which has an "AB" rating).
Generic Glyburide and Metformin
A patent currently prevents any generic glyburide and metformin from being manufactured. This eMedTV article explains that the earliest date a generic version of glyburide and metformin could become available is when the patent expires in 2020.
This eMedTV article explains that a patent currently prevents any generic inhaled insulin from being manufactured until 2010, when the patent expires. This page also warns against places claiming to sell a generic version of the medication.
At this point, Janumet is not available in generic form. As this section of the eMedTV library explains, generic Janumet is expected to become available in February 2019 (at the earliest), when the first patent for the diabetes medication expires.
As this eMedTV Web page explains, the FDA has recently determined which generic levothyroxine products are equivalent to the brand-name medications. This page also discusses the past problems with generic levothyroxine products.
This eMedTV article explains that a patent currently prevents any generic nateglinide from being manufactured until 2009, when the patent expires. This page also offers a warning about companies claiming to sell a generic version of the drug.
There is currently no generic pioglitazone for sale in the United States. As this portion of the eMedTV archives explains, however, several drug companies are expected to produce a generic pioglitazone medicine as soon the patent expires in 2011.
There is no approved generic pramlintide available in the United States. As this eMedTV page explains, the earliest a generic form of the drug could be available is in March 2010. This article also warns of the dangers of fake generic pramlintide.
A patent currently prevents any generic rosiglitazone from being manufactured and sold. This eMedTV resource explains that the earliest date that a generic version of rosiglitazone could become available is in 2012, when the patent expires.
Generic Rosiglitazone and Glimepiride
A patent currently prevents any generic rosiglitazone and glimepiride from being manufactured and sold. This eMedTV article explains that the earliest date a generic version of rosiglitazone and glimepiride could become available is in 2012.
Generic Synthroid is sold under a variety of different names and in 12 different strengths. This portion of the eMedTV library explains how the FDA has determined that certain generic versions of Synthroid are equivalent to the brand-name medication.
Since Westhroid (thyroid USP) is not FDA-approved, there are no official generic Westhroid products. As this eMedTV page explains, many generic drugs have the same ingredients as Westhroid, but it is hard to tell if they are actually equivalent.
This portion of the eMedTV library describes how glimepiride can lower blood sugar levels in people with type 2 diabetes. This segment also explains some symptoms of a glimepiride overdose. Glimeperide is a common misspelling of glimepiride.
Glimepiride is a prescription medicine used to control blood sugar in people with type 2 diabetes. This eMedTV article explains how glimepiride works by increasing insulin production and also highlights dosing guidelines and potential side effects.
This eMedTV article explores glimepiride and depression, explaining that depression does not appear to be a common or rare side effect of glimepiride. This page also explains what to do if you notice any symptoms of depression while taking the drug.
Generally, people with type 2 diabetes may be given a starting dose of 1 mg or 2 mg of glimepiride. This eMedTV page covers some glimepiride dosing guidelines and tips on when and how to take the drug. The dose can be slowly increased if necessary.
This eMedTV article explains that glimepiride helps to treat type 2 diabetes by lowering blood sugar levels. This page also lists possible side effects and explains what will determine your dosage. Glimiperide is a common misspelling of glimepiride.
Glipizide and metformin is a prescription medicine that lowers blood sugar in people with type 2 diabetes. This eMedTV resource explains how the medication works to control blood sugar, lists possible side effects, and offers dosing information.